Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure

Journal of the American College of Cardiology

Volumn 32, Issue 5, 1998, Pages 1179-1186

  Stein, Birgitt ^a   Eschenhagen, Thomas ^a   Rüdiger, Jochen ^a   Scholz, Hasso ^a   Förstermann, Ulrich ^b   Gath, Ingolf ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MESSENGER RNA; NITRATE; NITRIC OXIDE SYNTHASE; RIBONUCLEASE;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME LOCALIZATION; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MYOCARDITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; TISSUE DONORS;

EID: 0032211062     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00399-4     Document Type: Article

References (50)

1. Förstermann U, Closs E, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions. Hypertension 1994;23:1121-31.
2. Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol 1992;11:1921-30.
3. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-6.
4. Balligand J-L, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthase in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993a; 91:2314-9.
5. Stein B, Frank P, Schmitz W, Scholz H. Long-term treatment of cardiomyocytes with endotoxins and cytokines induces negative inotropic effects mediated by nitric oxide. In: Moncada S, Marletta MA, Hibbs JB Jr, Higgs EA, editors. Biology of Nitric Oxide. London: Portland Press Proceedings, 1993;II:85-9.
6. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-α. Br J Pharmacol 1995;114:27-34.
7. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996;28:1631-9.
8. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Mitchel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 1993b;90:347-51.
9. Balligand J-L, Kobzik L, Han X, et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;70:14582-6.
10. Pötzl J, Jakob H, Rüdiger J, Scholz H, Stein B. Negative chronotropic effects of R-phenylisopropyladenosine and carbachol are mediated by nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 1996;213 Suppl I.
11. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92:2198-203.
12. Mohan P, Brutsaert DL, Pulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996;93:1223-9.
13. Finkel MS, Oddis CV, Mayer H, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther 1995;272:945-52.
14. Kaye DM, Wiviott SD, Balligand J-L, Simmons WW, Smith TW, Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res 1996;78:217-24.
15. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-80.
16. ++-dependent constitutive nitric oxide synthase is not involved in the cyclic cGMP-increasing effects of carbachol in ventricular cardiomyocytes. J Pharmacol Exp Ther 1993;266:919-25.
17. Kennedy RH, Hicks KK, Brian JE Jr, Seifen E. Nitric oxide has no chronotropic effect in right atria isolated from rat heart. Eur J Pharmacol 1994;255:149-56.
18. Nawrath H, Bäumner D, Rupp J, Oelert H. The ineffectiveness of the NO-cyclic GMP signaling pathway in atrial myocardium. Br J Pharmacol 1995;116:3061-7.
19. Kilter H, Lenz O, La Roseé K, et al. Evidence against a role of nitric oxide in the indirect negative inotropic effect of M-cholinoceptor stimulation in human ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 1995;352:308-12.
20. Decking UKM, Flesche CW, Gödecke A, Schrader J. Endotoxin-induced contractile dysfunction in guinea-pig hearts is not mediated by nitric oxide. Am J Physiol 1995;268:H2460-5.
21. Fischmeister R, Méry PF. Regulation of cardiac Ca2+ channels by cGMP and NO. In: Morad M, Ebashi S, Trautwein W, Kurachi Y, editors. Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Kleuwer Academic Publishers, Dordrecht, Boston, London, 1996:93-105.
22. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
23. Muleri LA, Hasefuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-50.
24. Katz AM. Is heart failure an abnormality of myocardial cell growth? Cardiology 1990;77:346-56.
25. Narulara J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;17:1182-9.
26. Gwathmey JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-6.
27. Kawaguchi H, Shim WS, Wang Y, et al. In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Circulation 1997;95:2441-7.
28. De Belder AI, Randomski MW, Why HJF, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
29. De Belder AI, Randomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischemic or valvar heart disease. Br Heart J 1995;74:426-9.
30. Haywood GA, Tsao PS, von der Leyen H, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94.
31. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347:1151-5.
32. Satoh M, Nakamura M, Tamura G, et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997;29:716-24.
33. Thoenes M, Förstermann U, Tracey WR, et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 1996;28:165-9.
34. Wei CM, Jiang S-W, Lust JA, Daly RC, McGregor CGA. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin Proc 1996;71:346-50.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987;162:156-9.
36. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-5.
37. Marsden PA, Scheppert KT, Chen HS, et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992;307:287-93.
38. Eschenhagen T, Mende U, Nose M, et al. Increased messenger RNA level of the inhibitory G protein α-subunit Giα2 in human end-stage heart failure. Circ Res 1992;70:688-96.
39. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976;72:248-54.
40. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing factor VIII antigen established by hybridization. Proc Natl Acad Sci USA 1983;80:3734-9.
41. Khadour FH, Kao RH, Park S, Armstrom PW, Holycross BJ, Schulz R. Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure. Am J Physiol 1997;273:H1223-30.
42. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-53.
43. Smith CJ, Sun D, Hoegler C, et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996;78:58-64.
44. Winlaw DS, Smythe GA, Koegh AM, Schyvens CG, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet 1994;344:373-4.
45. Kichuk MR, Seyedi N, Zhang X, et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996;94:44-51.
46. Zaho G, Shen W, Zhang X, Smith CJ, Hintze TH. Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow. Clin Exp Pharmacol Physiol 1996;23:715-21.
47. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 1991;88:1197-201.
48. Wahler G, Dollinger SJ. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Cell Physiol 1995;37:C45-54.
49. Kirstein M, Rivet-Bastide M, Hatem S, Bénardeau A, Mercardier J-J, Fischmeister R. Nitric oxide regulates calcium current in isolated human atrial myocytes. J Clin Invest 1995;95:794-802.
50. Yamamoto S, Tsutsui H, Tagawa H, et al. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure. Circulation 1997;95:1111-4.